# Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)

> **NCT05275686** · PHASE2 · RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Eustachian Tube Dysfunction

## Interventions

- **DRUG:** Fluticasone Propionate 93 MCG/1 ACTUATION Nasal Spray
- **OTHER:** Placebo Nasal Spray

## Key facts

- **NCT ID:** NCT05275686
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-20
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05275686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05275686, "Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05275686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*